Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice

CD4+ Th-APC with Acquired Peptide/MHC Class I and II Complexes Stimulate Type 1 Helper CD4+ and Central Memory CD8+ T Cell Responses

(2014) C. S. Umeshappa et al.   JOURNAL OF IMMUNOLOGY

Anti-HER2 vaccines: new prospects for breast cancer therapy

(2010) Maha Zohra Ladjemi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination

(2009) N. Grinshtein et al.   CANCER RESEARCH

The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

(2009) L. C. Benavides et al.   CLINICAL CANCER RESEARCH

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer

(2009) Mary L. Disis et al.   JOURNAL OF CLINICAL ONCOLOGY

Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice

(2008) S Sas et al.   CANCER GENE THERAPY

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy

(2008) Constantin N. Baxevanis et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

DNA Vaccination Controls Her-2+ Tumors that Are Refractory to Targeted Therapies

(2008) P. J. Whittington et al.   CANCER RESEARCH

Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/neu Vaccine

(2008) J. M. Park et al.   CANCER RESEARCH

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

(2008) Nicolas Whenham et al.   Clinical Breast Cancer

Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells

(2007) Khalil Karimi et al.   MOLECULAR THERAPY